Evanaz
5 years ago
Hey Jugs!
Listen, I was told about AVITA approximately a year ago when it was still on the OTC at 1.93, i bought 1000 shares then, at that price and then at$3,35 and then 5.00, and then 7.75 which I think was around the time it became RCEL on the Nasdaq. Also bought today at 10.39
Point is that Polynovoβs product works well withRecell and it is patented. I see no reason that their product βNovosorbβ wonβt continue to grow alongside Recell, however, Novosorb is also being used in a number of other applications aside from burn treatments.
Having said that, poly will soon need a cash infusion and even if novasorb becomes a standard of care product/process, it is unlikely it will ever be on the level of game changer like Avita is in my humble opinion.
Nonetheless, it should be worth $5 in the near future and who knows beyond that. Im in for 450 shares at 2.10 and will keep following
jugs
5 years ago
Here goes:
Now holding 2,000 shares of Polynovo with an average cost basis of $2.17.
Nothing outlandish there so far as I'm underwater to the tune of $83.
But---and note I didn't say "BUTT!"
The rub here is that my current holding represents 14.6% of the daily AVERAGE trading volume for this stock!
It should be noted here that I have never sought to control the volumetric side of any stock I've held. By that I mean that if I were to put my shares up for sale in one fell swoop or one swell poop, sure---I'd effectively be rocking the company's boat.
I've never engaged in such business I'd have to call immoral. The only control I seek outside of gaining a profit through trading honestly is trying to be of service to others. Still, if I'm right in sensing that CALZF is going to fly much, much higher in the months ahead, then trading volumetrics will most assuredly rise well above current numbers. It is to be hoped that we investors will be in the receiving line.
Good fortune to all here!
jugs
5 years ago
Just picked up 300 shares of CALZF, improving my cost basis as I add.
That cost basis is now a $2.19 and I'm holding just 1,300 shares.
Granted, it's just a wee bit of the position that never was. (Huh?)
But it feels like a start.
Back not quite a year ago I launched my RCEL position(s) and now hold almost 72,000 shares. I'm all over it today being as the price is down into the low $10.30 range.
There's no way I could envision building a similar position in CALZF but I'm patient enough to avail myself of the opportunity to add while "working" the share price. And it's so cheap, I'm not concerned with the potential for loss---not yet, anyhow.
Good luck prospecting!
jugs
5 years ago
It finally dawned on me that this could be the right time for me to take the opportunity to dip my fingers into Polynovo. (CALZF)
I've been an ardent supporter of Avita (RCEL) for about a year. I try to contribute here at the IHUB board, focusing not so much on the medical technology but, rather, how to approach investing in this stock. And now I've placed a tiny bet on Polynovo, explanation to follow:
Starting with just 300 shares this morning at $2.40 and buying a few more at lower prices, I now stand at:
1,000 shares of CALZF with an average cost of $2.21. This includes the $6/trade charged by Ameritreade for Pink sheet designations. It should be noted that while I will not involve myself in pinks, this is a special instance as the "F" attached to the ticker symbol is the only way this stock domiciled in Australia can be traded here in the States. It is not about the stock and its quality. It is solely about machinery set up to handle large-scale brokerage trading business.
I'll be sitting on this stock pick, hoping to add some more as we go forward.
Even the most cursory look will reveal that, as with RCEL, CALZF, too, has shown remarkable acceptance in the burn business. It has yet to catch on with the U.S. audience, I believe. Trading volume is remarkably low. If I can build my position from here, I might just move past petty concerns about volumetrics working against my trading instincts.
There is a frequent concern raised that the two stocks mentioned within this post are in competition with one another. Nothing could be further from the truth.
As a matter of fact, the thing propelling me to launch my position hit me before I was fully awake---I'm thinking it's possible that Avita and Polynovo just might be considering a merger of some sort. It would make a lot of sense to me in some respects but I'm not prepared to present a case for such a transaction. However, Polynovo has some things in its arsenal that I believe could prove to be of immense value to Avita in terms of their respective medical technological breakthroughs.
As for Poly jumping in bed with Avita? Think of it as though Poly were in search of a reverse merger opportunity. Avita is traded on a global stage via NASD. Poly has no such trading platform available, thus necessitating the Pink sheet status. That suggests in my mind at least that this might just become a marriage made in Heaven.
It would be great to hear from others on this subject.
Looking forward.....